PHP
VCYT icon

Parkman Healthcare Partners’s Veracyte VCYT Stock Holding History

Parkman Healthcare Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26M Buy
101,237
+968
+1% +$35.8K 0.34% 74
2025
Q4 		$4.22M Sell
100,269
-122,796
-55% -$4.95M 0.4% 67
2025
Q3 		$7.66M Buy
223,065
+2,678
+1% +$76.8K 0.8% 47
2025
Q2 		$5.96M Buy
220,387
+54,109
+33% +$1.57M 0.68% 55
2025
Q1 		$4.93M Buy
166,278
+65,977
+66% +$2.51M 0.58% 50
2024
Q4 		$3.97M Sell
100,301
-28,959
-22% -$1.1M 0.53% 50
2024
Q3 		$4.4M Sell
129,260
-80,215
-38% -$2.26M 0.56% 58
2024
Q2 		$4.54M Sell
209,475
-44,617
-18% -$938K 0.61% 58
2024
Q1 		$5.63M Buy
254,092
+16,776
+7% +$409K 0.69% 49
2023
Q4 		$6.53M Buy
237,316
+11,444
+5% +$276K 0.92% 36
2023
Q3 		$5.04M Buy
225,872
+13,912
+7% +$358K 0.92% 36
2023
Q2 		$5.4M Buy
211,960
+93,338
+79% +$2.26M 0.94% 33
2023
Q1 		$2.65M Buy
118,622
+896
+0.8% +$21.7K 0.58% 51
2022
Q4 		$2.79M Buy
117,726
+56,843
+93% +$1.32M 0.74% 50
2022
Q3 		$1.01M Sell
60,883
-13,083
-18% -$294K 0.29% 70
2022
Q2 		$1.47M Buy
73,966
+13,315
+22% +$269K 0.54% 50
2022
Q1 		$1.67M Sell
60,651
-1,613
-3% -$46.1K 0.49% 51
2021
Q4 		$2.56M Buy
62,264
+17,264
+38% +$763K 0.57% 46
2021
Q3 		$2.09M Buy
+45,000
New +$1.96M 0.53% 52

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Parkman Healthcare Partners's VCYT Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Veracyte (VCYT) stake by 0.97% in Q1 2026, buying an estimated $35.8K and bringing the position to 101,237 shares worth $3.26M. The position accounts for 0.34% of the portfolio, ranked #74.

Parkman Healthcare Partners first reported a position in VCYT in Q3 2021 and has held it in 19 quarters since. The position peaked at $7.66M in Q3 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Parkman Healthcare Partners held 101,237 shares of Veracyte worth $3.26M as of Q1 2026.
  • Parkman Healthcare Partners bought 968 Veracyte shares in Q1 2026, an estimated $35.8K.
  • Veracyte made up 0.34% of Parkman Healthcare Partners's portfolio in Q1 2026, its #74 holding.
  • Parkman Healthcare Partners first reported a position in Veracyte in Q3 2021 and has held it in 19 quarters since.
  • Parkman Healthcare Partners's Veracyte position peaked at $7.66M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.